Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Meat makes a meal, so goes the saying. But with more people than ever before ditching meat for plant-based alternatives, it seems meaty dishes are starting to go out of fashion.

An estimated 29% of evening meals contained no meat or fish in 2017, according to UK market research. And the reason for this is often linked to health. Research shows that eating red and processed meat is associated with an increased risk of heart diseasetype 2 diabetes, and bowel cancer.

Livestock production is also bad for the environment. It leads to deforestation, pollution of water, and emits greenhouse gases that heat up our planet. This environmental impact also takes a toll on human health – for example, a warmer climate enables malaria-carrying mosquitoes to spread faster and wider.

But despite the rise of lower meat diets, scientists continue to call for more people to reduce their meat consumption, which is essential to meet environmental and climate change targets.

Read the full article on The Conversation website, written by Filippo Bianchi, research student in the Nuffield Department of Primary Care Health Sciences. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Biological processes of ageing is key to improving later life health

Improvements in health care, sanitation, and diet over last 100 years have significantly increased life expectancy. However, this increase in how long we can expect to live has not been accompanied by a similar increase in healthy life expectancy, defined as the time spent free of major illness or disease.